0000899243-23-005363.txt : 20230217 0000899243-23-005363.hdr.sgml : 20230217 20230217080011 ACCESSION NUMBER: 0000899243-23-005363 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Jason S. CENTRAL INDEX KEY: 0001713925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 23640318 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BOULEVARD, SUITE 100 STREET 2: C/O MOLECULAR TEMPLATES, INC. CITY: AUSTIN STATE: TX ZIP: 78729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001183765 Molecular Templates, Inc. MTEM 0001713925 Kim Jason S. C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD., SUITE 100 AUSTIN TX 78729 0 1 0 0 See remarks Stock Option (right to buy) 0.4812 2023-02-15 4 A 0 170000 0.00 A 2033-02-14 Common Stock 170000 170000 D 25% of the shares subject to the option shall vest on February 15, 2024, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over the following 36 months. President, Chief Operating Officer, and Interim Chief Financial Officer /s/ Jason S. Kim 2023-02-17